The Coronary Artery Bypass Graft (CABG) Procedures Market was valued at USD 15.43 billion in 2025 and is projected to grow at a CAGR of 9.40% between 2026 and 2035, reaching approximately USD 37.89 billion by 2035. Market expansion is primarily driven by the increasing global burden of cardiovascular diseases (CVDs), advancements in surgical technologies, improved perioperative care, and expanding access to cardiac surgery in emerging economies.
CABG remains one of the most widely performed cardiac surgical procedures worldwide, particularly for patients with severe coronary artery disease (CAD) who are unsuitable for percutaneous coronary intervention (PCI) or require multi-vessel revascularization.
What Is Coronary Artery Bypass Grafting (CABG)?
Coronary Artery Bypass Grafting is a surgical procedure used to restore blood flow to the heart muscle by bypassing blocked or narrowed coronary arteries using graft vessels. These grafts are typically harvested from:
- Internal mammary arteries
- Radial arteries
- Saphenous veins
CABG improves myocardial perfusion, reduces angina symptoms, enhances survival in high-risk patients, and lowers the risk of major adverse cardiac events in selected populations.
Market Size & Forecast (2025–2035)
| Year | Market Value (USD Billion) |
|---|---|
| 2025 | 15.43 |
| 2035 | 37.89 |
| CAGR (2026–2035) | 9.40% |
The strong growth outlook reflects:
- Rising prevalence of coronary artery disease
- Increasing geriatric population
- Improved surgical outcomes
- Expanding cardiac care infrastructure
Despite advancements in minimally invasive PCI techniques, CABG continues to be recommended for complex multi-vessel disease and diabetic patients.
Key Market Drivers
1. Increasing Incidence of Cardiovascular Diseases
Cardiovascular diseases remain a leading cause of mortality globally. Risk factors such as obesity, diabetes, smoking, sedentary lifestyles, and hypertension are contributing to rising CAD cases, thereby increasing CABG procedure volumes.
2. Technological Advancements in Surgical Techniques
Innovations include:
- Off-pump CABG procedures
- Minimally invasive direct coronary artery bypass (MIDCAB)
- Robotic-assisted cardiac surgery
- Enhanced graft harvesting techniques
These advancements reduce operative risks, hospital stays, and complication rates.
3. Expanding Healthcare Infrastructure in Emerging Markets
Countries in Asia-Pacific, Latin America, and the Middle East are investing heavily in tertiary cardiac centers, increasing procedural capacity.
4. Improved Postoperative Outcomes
Enhanced recovery protocols, improved anesthesia, and better graft materials have reduced mortality and morbidity, encouraging higher adoption.
Market Segmentation Analysis
By Procedure Type
- On-Pump CABG
- Off-Pump CABG
- Minimally Invasive CABG
On-pump CABG remains widely practiced, while off-pump and minimally invasive techniques are gaining traction.
By End User
- Hospitals
- Cardiac Specialty Centers
- Ambulatory Surgical Centers
Hospitals account for the largest market share due to advanced surgical facilities and intensive care requirements.
By Graft Type
- Arterial Grafts
- Venous Grafts
Arterial grafts are increasingly preferred due to better long-term patency rates.
By Region
- North America (Leading Market)
- Europe
- Asia-Pacific (High Growth Region)
- Rest of the World
North America leads due to established cardiac surgery infrastructure, while Asia-Pacific is witnessing rapid growth due to demographic and lifestyle changes.
Competitive Landscape
The CABG procedures market includes device manufacturers, surgical instrument providers, and perfusion technology companies.
Companies Covered (Reference List)
- Boston Scientific Corporation
- KARL STORZ GmbH & Co. KG
- Ethicon US, LLC
- Genesee Biomedical Inc.
- MAQUET Holding B.V. & Co. KG
- Others
Competitive Strategies
- Development of advanced surgical instruments
- Robotic surgery integration
- Expansion into emerging markets
- Partnerships with cardiac specialty centers
- R&D investment in graft materials
Companies are focusing on enhancing surgical precision, reducing complications, and improving patient recovery outcomes.
Emerging Trends
1. Robotic-Assisted CABG
Robotic systems are enabling smaller incisions, greater precision, and faster recovery times.
2. Hybrid Revascularization Procedures
Combination of CABG and PCI in hybrid operating rooms is becoming more common for complex CAD cases.
3. Personalized Risk Stratification
AI-driven predictive tools are assisting surgeons in selecting optimal revascularization strategies.
4. Growth in Outpatient Cardiac Care
Although CABG remains largely inpatient, shorter hospital stays and improved recovery protocols are reducing overall costs.
Market Challenges
- High procedural costs
- Limited access in low-income regions
- Risk of surgical complications
- Reimbursement pressures
- Competition from advanced PCI techniques
Long-term market sustainability will depend on balancing cost-effectiveness and clinical outcomes.
Strategic Opportunities (2026–2035)
- Expansion of robotic cardiac surgery systems
- Training programs for cardiac surgeons in emerging markets
- Development of next-generation graft materials
- Public-private partnerships in cardiac care infrastructure
- Integration of AI in perioperative management
Innovation in surgical precision and recovery optimization will remain central to competitive advantage.
FAQs
1. What is the size of the coronary artery bypass graft procedures market in 2025?
The market was valued at USD 15.43 billion in 2025.
2. What is the projected market value by 2035?
It is expected to reach approximately USD 37.89 billion by 2035.
3. What is the CAGR of the CABG procedures market?
The market is anticipated to grow at a CAGR of 9.40% from 2026 to 2035.
4. What is driving market growth?
Rising cardiovascular disease incidence, technological advancements in surgery, and expanding healthcare infrastructure are key growth drivers.
